Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04563338
Title An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto
Indications

hepatocellular carcinoma

lung non-squamous non-small cell carcinoma

Therapies

Atezolizumab

Atezolizumab + Bevacizumab

Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST